Inhibition of atherosclerosis by diindolylmethane analogs

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/404 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2567377

Diindolylmethane analogs such as 1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes can be used to treat atherosclerosis and other vascular disease states. The analogs have been shown to display antiinflammatory effects in endothelial cells, suggesting their clinical applicability.

L'invention concerne des analogues de di-indolylméthane, notamment des 1,1-bis(3'-indolyl)-1-(p-substitué phényl)méthanes pouvant être utilisés pour traiter l'athérosclérose et d'autres maladies vasculaires. Ces analogues présentent des effets anti-inflammatoires dans des cellules endothéliales, ce qui suggère des possibilités dans des applications cliniques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibition of atherosclerosis by diindolylmethane analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of atherosclerosis by diindolylmethane analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of atherosclerosis by diindolylmethane analogs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1649945

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.